Literature DB >> 27161529

Anatomical Variations of the Transverse-Sigmoid Sinus Junction: Implications for Endovascular Treatment of Idiopathic Intracranial Hypertension.

Michael W McCormick1, Harrison G Bartels1, Analiz Rodriguez1, James E Johnson1, Rashid M Janjua1.   

Abstract

Venous sinus pathology can result in multiple pathological diseases, including idiopathic intracranial hypertension (IIH). There remains a paucity of information on anatomical luminal variations of the major venous sinuses which may contribute to the etiology of certain disease states. Thirty-six transverse and sigmoid sinuses were removed following dissection of 19 unfixed cadaveric heads. Sinuses were opened longitudinally to study luminal variations. A semiquantitative classification system was developed to assess septations and blind pouches. Seventy-nine percent of cadavers had a luminal anatomical variation. Forty-four percent and 42% of sinuses dissected had occurrence of a septations or blind pouches, respectively. Thirty percent of septations and 25% of pouches were classified as large. Incidence of anatomical variations was not statistically significant between cadaver gender or sinus laterality. Luminal variations are present in the transverse and sigmoid sinuses at rates higher than expected. This study is the first to report the presence of blind pouches in the luminal wall of transverse and sigmoid sinuses. These variations can have clinical importance to the endovascular surgeon and may also contribute to the pathophysiological etiology of venous sinus diseases. Anat Rec, 299:1037-1042, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  dural venous sinus; idiopathic intracranial hypertension; venous septations; venous sinus stenosis

Mesh:

Year:  2016        PMID: 27161529     DOI: 10.1002/ar.23370

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  7 in total

1.  Unexpected occlusion of the contralateral transverse sinus after stenting for idiopathic intracranial hypertension.

Authors:  Stephanie A Coffman; Jasmeet Singh; Stacey Wolfe; Kyle M Fargen
Journal:  Interv Neuroradiol       Date:  2018-07-05       Impact factor: 1.610

2.  Contralateral approach to transverse-sigmoid sinus stenting.

Authors:  Weston Gordon; Michael Abraham
Journal:  Interv Neuroradiol       Date:  2020-08-30       Impact factor: 1.610

3.  Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations.

Authors:  Robert Kyle Townsend; Alec Jost; Matthew R Amans; Ferdinand Hui; Matthew T Bender; Sudhakar R Satti; Robert Maurer; Kenneth Liu; Waleed Brinjikji; Kyle M Fargen
Journal:  J Neurointerv Surg       Date:  2021-04-28       Impact factor: 5.836

4.  Balloon anchoring to traverse the sigmoid sinus for delivery of large-caliber venous stents: A technical note.

Authors:  Tomoaki Murakami; Shingo Toyota; Takuya Suematsu; Yuki Wada; Kanji Nakagawa; Takeshi Shimizu; Kanji Mori; Takuyu Taki
Journal:  Interv Neuroradiol       Date:  2021-02-17       Impact factor: 1.764

5.  A retrospective anatomical study of the cerebral dural venous sinus outflow pathways utilizing three-dimensional rotational venography.

Authors:  Adrish Anand; Samantha Claire Crowley; Aditya Srivatsan; Visish M Srinivasan; Gouthami Chintalapani; Peter Kan; Jeremiah N Johnson
Journal:  Brain Circ       Date:  2022-03-21

Review 6.  Advances in the Understanding of the Complex Role of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension.

Authors:  Kexin Zhao; Wenjing Gu; Chunmei Liu; Derui Kong; Chong Zheng; Wei Chen; Xuewei Li; Yuchen Liang; Hongwei Zhou
Journal:  J Magn Reson Imaging       Date:  2022-03-31       Impact factor: 5.119

7.  Casper Versus Precise Stent for the Treatment of Patients with Idiopathic Intracranial Hypertension.

Authors:  Nebiyat F Belachew; Severin Baschung; William Almiri; Ruben Encinas; Johannes Kaesmacher; Tomas Dobrocky; Christoph J Schankin; Mathias Abegg; Eike I Piechowiak; Andreas Raabe; Jan Gralla; Pasquale Mordasini
Journal:  Clin Neuroradiol       Date:  2021-05-18       Impact factor: 3.649

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.